Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topiramate in PTSD
NCT00204386Phase 3Completed
- Sponsor
- University of Oklahoma
- Start
- Sep 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in post-traumatic stress disorder (PTSD) comparing Topiramate with Placebo (2 arms). Primary endpoint: Clinician-Administered PTSD Scale at 12 weeks. Started Sep 2002; status: completed.
02
Drugs
topiramate
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT00204386.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00204386.